Skip to main content

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

DyLight 405 (Excitation = 400 nm, Emission = 420 nm)

Antibody Source

Monoclonal Mouse IgG1 Clone # OTI1E3

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Full length recombinant protein of human BCA3 (NP_878904) produced in E.coli.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Applications for BCA3 Antibody (OTI1E3) [DyLight 405]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: BCA3

Alternate Names

AKIP1koyt binding protein 2, BCA3koyt binding protein 3, breast cancer associated gene 3, Breast cancer-associated gene 3 protein, chromosome 11 open reading frame 17, koyt binding protein 1, PKA-interacting protein, proline-rich protein BCA3, protein kinase A-interacting protein 1

Gene Symbol

AKIP1

Additional BCA3 Products

Product Documents for BCA3 Antibody (OTI1E3) [DyLight 405]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for BCA3 Antibody (OTI1E3) [DyLight 405]



DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...